Treatment for Vaginal Itching After Menopause
Vaginal estrogen therapy is the most effective treatment for postmenopausal vaginal itching and associated symptoms of vaginal atrophy. 1
Understanding Vaginal Itching After Menopause
- Vaginal itching is a common symptom of vaginal atrophy (also called genitourinary syndrome of menopause), affecting approximately 50% of postmenopausal women due to decreased estrogen levels 1, 2
- Associated symptoms include vaginal dryness, burning sensation, discomfort, pain during intercourse (dyspareunia), and vaginal discharge 1, 2
- Unlike vasomotor symptoms (hot flashes) which tend to resolve over time, vaginal atrophy symptoms typically persist indefinitely and often worsen without treatment 1
Treatment Algorithm
First-Line: Non-Hormonal Options
- Regular use of over-the-counter vaginal moisturizers for daily maintenance to relieve dryness and discomfort 1, 3
- Water-based or silicone-based lubricants during sexual activity (silicone-based products may last longer) 1, 4
- Topical products containing hyaluronic acid, vitamin E, and vitamin A can help prevent vaginal mucosal inflammation, dryness, and bleeding 1, 3
Second-Line: Hormonal Treatments
- Vaginal estrogen therapy is the most effective treatment when non-hormonal options fail to provide adequate relief 1, 5
- Available in several forms:
- Low-dose formulations minimize systemic absorption while effectively treating symptoms 1, 6
- A large cohort study of almost 50,000 patients with breast cancer followed for up to 20 years showed no evidence of increased breast cancer-specific mortality in those using vaginal estrogen 5
Additional Treatment Options
- Vaginal DHEA (prasterone) is FDA-approved for vaginal dryness and pain with sexual activity 1, 5
- Ospemifene, an FDA-approved selective estrogen receptor modulator (SERM), effectively treats vaginal dryness and dyspareunia 5, 1
- Not recommended for women with a history of estrogen-dependent cancers 5
- Pelvic floor physical therapy can improve sexual pain, arousal, lubrication, and satisfaction 5, 1
- Vaginal dilators may help with pain during sexual activity and increase vaginal accommodation 5, 1
- Topical anesthetics may help with vaginal pain 5
Special Considerations
- For women with a history of hormone-sensitive cancers:
- Vaginal estradiol may increase circulating estradiol in aromatase inhibitor users, potentially reducing the efficacy of these medications 1
- Without treatment, symptoms of vaginal atrophy typically worsen over time 1, 7
Monitoring and Follow-up
- Re-evaluate symptoms at regular intervals to assess treatment effectiveness 5
- Monitor for adverse effects, particularly if using hormonal treatments 6
- For women using vaginal estrogen, be aware of potential side effects including vaginal bleeding, which should be promptly reported to healthcare provider 6